Adult Immunization Programs in Nontraditional Settings: Quality Standards and Guidance for Program Evaluation
Overview
Authors
Affiliations
This report provides a summary of the National Vaccine Advisory Committee's (NVAC) workshop on adult immunization programs in nontraditional settings, quality standards for such programs, and guidance for program evaluation. Throughout the United States, an increasing number of adults are receiving vaccine in nontraditional settings (e.g., pharmacies and churches). Immunization programs in nontraditional settings are often more accessible and convenient than a health-care provider's office or a public health clinic, especially for medically underserved adults (e.g., economically disadvantaged, inner city, and minority populations). Medically underserved adults might be at particular risk for undervaccination because they are often without a medical home (i.e., a regular point of contact where their health-care needs are met). Immunization programs in nontraditional settings might enhance the capacity of the health-care system to effectively deliver vaccine to adults by increasing the number and types of sites where adults can receive vaccine. NVAC has recognized that strategies need to be developed to make vaccines available to all adults and that the number of immunization programs in nontraditional settings is increasing. Therefore, the Committee issues the following report, including quality standards and guidance for program evaluation.
Larson A, Skolnik A, Bhatti A, Mitrovich R Hum Vaccin Immunother. 2021; 18(1):1975453.
PMID: 34674605 PMC: 8920227. DOI: 10.1080/21645515.2021.1975453.
Daniel C, Lawson F, Vickers M, Green C, Wright A, Coyne-Beasley T BMC Public Health. 2021; 21(1):1266.
PMID: 34187438 PMC: 8240772. DOI: 10.1186/s12889-021-11304-8.
Tan H, Phang C, Wu S, Sim M, Law M, Foo M Int Urol Nephrol. 2021; 53(10):2167-2175.
PMID: 33675479 DOI: 10.1007/s11255-021-02817-7.
Lu P, Srivastav A, Santibanez T, Amaya A, Dever J, Roycroft J Am J Infect Control. 2020; 49(5):555-562.
PMID: 33038459 PMC: 9077541. DOI: 10.1016/j.ajic.2020.09.016.
Hung M, Lu P, Srivastav A, Cheng Y, Williams W Vaccine. 2020; 38(42):6545-6552.
PMID: 32819730 PMC: 9063722. DOI: 10.1016/j.vaccine.2020.08.008.